The Hill equation: a review of its capabilities in pharmacological modelling
- PMID: 19049668
- DOI: 10.1111/j.1472-8206.2008.00633.x
The Hill equation: a review of its capabilities in pharmacological modelling
Abstract
The Hill equation was first introduced by A.V. Hill to describe the equilibrium relationship between oxygen tension and the saturation of haemoglobin. In pharmacology, the Hill equation has been extensively used to analyse quantitative drug-receptor relationships. Many pharmacokinetic-pharmacodynamic models have used the Hill equation to describe nonlinear drug dose-response relationships. Although the Hill equation is widely used, its many properties are not all well known. This article aims at reviewing the various properties of the Hill equation. The descriptive aspects of the Hill equation, in particular mathematical and graphical properties, are examined, and related to Hill's original work. The mechanistic aspect of the Hill equation, involving a strong connection with the Guldberg and Waage law of mass action, is also described. Finally, a probabilistic view of the Hill equation is examined. Here, we provide some new calculation results, such as Fisher information and Shannon entropy, and we introduce multivariate probabilistic Hill equations. The main features and potential applications of this probabilistic approach are also discussed. Thus, within the same formalism, the Hill equation has many different properties which can be of great interest for those interested in mathematical modelling in pharmacology and biosciences.
Similar articles
-
The quantitative analysis of drug-receptor interactions: a short history.Trends Pharmacol Sci. 2006 Mar;27(3):149-57. doi: 10.1016/j.tips.2006.01.008. Epub 2006 Feb 17. Trends Pharmacol Sci. 2006. PMID: 16483674 Review.
-
Principles of pharmacodynamics and their applications in veterinary pharmacology.J Vet Pharmacol Ther. 2004 Dec;27(6):397-414. doi: 10.1111/j.1365-2885.2004.00620.x. J Vet Pharmacol Ther. 2004. PMID: 15601436 Review.
-
A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data.Drug Metab Dispos. 1999 Dec;27(12):1479-87. Drug Metab Dispos. 1999. PMID: 10570030
-
Pharmacodynamic models: parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models.J Biopharm Stat. 2013 May;23(3):648-61. doi: 10.1080/10543406.2012.756496. J Biopharm Stat. 2013. PMID: 23611201
-
Connection of pharmacokinetics and pharmacodynamics--how does it work?Int J Clin Pharmacol Ther. 1997 Oct;35(10):414-7. Int J Clin Pharmacol Ther. 1997. PMID: 9352389
Cited by
-
The Terminal Oxidase Cytochrome bd Promotes Sulfide-resistant Bacterial Respiration and Growth.Sci Rep. 2016 Mar 31;6:23788. doi: 10.1038/srep23788. Sci Rep. 2016. PMID: 27030302 Free PMC article.
-
A Minimal PKPD Interaction Model for Evaluating Synergy Effects of Combined NSCLC Therapies.J Clin Med. 2020 Jun 12;9(6):1832. doi: 10.3390/jcm9061832. J Clin Med. 2020. PMID: 32545464 Free PMC article.
-
Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin.Drug Deliv Transl Res. 2022 Mar;12(3):629-646. doi: 10.1007/s13346-021-00972-z. Epub 2021 Apr 15. Drug Deliv Transl Res. 2022. PMID: 33860446
-
Modeling and Parameter Subset Selection for Fibrin Polymerization Kinetics with Applications to Wound Healing.Bull Math Biol. 2021 Mar 22;83(5):47. doi: 10.1007/s11538-021-00876-6. Bull Math Biol. 2021. PMID: 33751272 Free PMC article.
-
Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy.PLoS Comput Biol. 2015 Mar 19;11(3):e1004142. doi: 10.1371/journal.pcbi.1004142. eCollection 2015 Mar. PLoS Comput Biol. 2015. PMID: 25789469 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources